Rel/NF-kappaB/IkappaB proteins and cancer.
Gilmore
T D
TD
Department of Biology, Boston University, Massachusetts 02215-2406, USA.
Koedood
M
M
Piffat
K A
KA
White
D W
DW
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D002645:Chickens; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D016356:Gene Products, tax / Q000502:physiology; D051379:Mice; D016328:NF-kappa B / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D009369:Neoplasms / Q000209:etiology* / Q000821:virology; D009856:Oncogene Proteins, Viral / Q000502:physiology; D011518:Proto-Oncogene Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction; D013329:Structure-Activity Relationship; D015534:Trans-Activators / Q000502:physiology; D051841:Transcription Factor RelB; D014157:Transcription Factors; D014763:Viral Matrix Proteins / Q000502:physiology; D054334:Viral Regulatory and Accessory Proteins
C037662:EBV-associated membrane antigen, Epstein-Barr virus; D016356:Gene Products, tax; D016328:NF-kappa B; D009856:Oncogene Proteins, Viral; D011518:Proto-Oncogene Proteins; C497594:Relb protein, mouse; D015534:Trans-Activators; D014157:Transcription Factors; D014763:Viral Matrix Proteins; D054334:Viral Regulatory and Accessory Proteins; C057628:hepatitis B virus X protein; D051841:Transcription Factor RelB